nanoTox opens subsidiary in Maastricht
30-3-2006
The emergence of nanotechnology has ignited a revolution in products and the industries that manufacture them. Governments and private investors worldwide clearly recognize nanotechnology's potential and are investing substantially in its development within critical markets. But there are questions about potential hazards affecting the safety and welfare of consumers and those involved in the manufacturing, as well as the potential for large-scale environmental risks.
nanoTox™ has the expertise and know-how to help advance safe nanotechnology products into multiple market sectors. nanoTox™ performs and standardizes the characterization of nanoscale materials intended for use in commercial products and developed by researchers from academia, government, and industry.
The company serves as an international resource and knowledge base for all stakeholders involved in nanotechnology, and facilitates the development and translation of nanoscale materials and devices for commercial applications.
BioPartner Center Maastricht welcomes this new tenant.
